1. Home
  2. INTS vs MTEN Comparison

INTS vs MTEN Comparison

Compare INTS & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.42

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Logo Mingteng International Corporation Inc. Ordinary Shares

MTEN

Mingteng International Corporation Inc. Ordinary Shares

HOLD

Current Price

$0.64

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
MTEN
Founded
2012
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
24.3M
IPO Year
2023
2024

Fundamental Metrics

Financial Performance
Metric
INTS
MTEN
Price
$0.42
$0.64
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.33
N/A
AVG Volume (30 Days)
3.3M
138.0K
Earning Date
11-06-2025
10-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,735,337.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.63
52 Week Low
$0.19
$0.80
52 Week High
$3.17
$26.03

Technical Indicators

Market Signals
Indicator
INTS
MTEN
Relative Strength Index (RSI) 47.72 14.91
Support Level $0.46 $0.80
Resistance Level $0.54 $1.26
Average True Range (ATR) 0.06 0.25
MACD 0.00 0.07
Stochastic Oscillator 27.71 3.15

Price Performance

Historical Comparison
INTS
MTEN

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: